About the Author
Aaron Lukas, Ph.D is a Registered Patent Attorney and an associate in the Hatch Waxman & Biologics Litigation Practice Group at Cozen O’Connor. Prior to moving in to law, Dr. Lukas was a Senior Research Scientist at Air Products and Chemicals, Inc., where his research resulted in more than 10 issued patents. He also served as a Graduate Research Assistant at Northwestern University's International Center for Nanotechnology and Department of Chemistry.
A recent decision from the Delaware District Court held that the composition of matter patent for the drug Baraclude was invalid as obvious. This opinion has drawn immediate attention because it is the first time that a lead compound obviousness challenge has succeeded in a district court since KSR v....
Most Popular Articles
From Bloomberg BNA
From Merrill DataSite
From Click 4 Compliance
From AllClear ID
From FTI Technology
From HP eDiscovery
September 22, 2015 at 2:00 pm ET
October 20, 2015 at 2:00 pm ET
Get the latest business trends, current corporate litigation, labor developments, technology initiatives and more.
Sign up to receive InsideScoop — FREE
You have been subscribed! You will receive a confirmation email soon.